Zhejiang Huahai Pharmaceutical Co., Ltd. Stock: price and insider trades · China
华海药业
No insider purchase over the last 90 days. The latest, by 陈保华, was filed 27 Nov 2023.
Zhejiang Huahai Pharmaceutical Co., Ltd.: what insiders have been doing
Zhejiang Huahai Pharmaceutical Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Nothing new has been filed by managers of Zhejiang Huahai Pharmaceutical Co., Ltd. in twelve months, the latest record being from 27 November 2023.
Looking back to 2023, when coverage begins, insiders filed 3 purchases and no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- +11.4%Entry CN¥15.77 · Close at T+365 CN¥17.57
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Zhejiang Huahai Pharmaceutical Co., Ltd. Hold (neutral), based on 3 analysts. Average price target: CN¥18.83.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 320,000 shares25.2% of flowA股XSHGSSE:173000007125983420Canonical exit: 25 Feb 2024 (T+90)
- 300,000 shares24.1% of flowA股XSHGSSE:173000007110825470Canonical exit: 21 Feb 2024 (T+90)
- 640,000 shares50.8% of flowA股XSHGSSE:173000007105043230Canonical exit: 19 Feb 2024 (T+90)
3 of 3 declarations
About Zhejiang Huahai Pharmaceutical Co., Ltd.
华海药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of generic drugs and innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
